• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Financial Services·TNBI
Share

Tanke Biosciences Corporation Stocks

$ 0.03Last Updated 20.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 380249

$ 0.03
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its business into four distinct categories: organic trace mineral additives, functional regulation additives, herbal medicinal additives, and other related offerings. Among its product lineup, Tanke Biosciences provides organic trace mineral additives marketed under the Qili brand. It also produces Qilicid feed acidifiers, which are crucial for preventing microbial spoilage of raw ingredients and finished animal feeds. The company's offerings further include various seasonings and Tankeball branded flavor enhancers, designed to act as agents in the creation of blended feeds. For those seeking herbal solutions, Extra-Health, Qilimix, and Recoccider are names associated with its herbal medicinal additives, which are incorporated directly into feed products. Moreover, Tanke Biosciences manufactures and distributes a wide array of trace mineral premix products for livestock and poultry, also under the Qilimix label. Its Tankeball brand extends to natural sweeteners and attractants, specifically formulated for pigs, piglets, fish, and other aquatic animals. Another key product is a water-soluble organic multi-vitamin electrolyte, intended to be dissolved in drinking water for easy animal consumption. The company caters to a broad customer base, encompassing medium to large-scale feed production factories, major livestock operations, and individual farmers. Its products are primarily distributed and sold across the People's Republic of China, Southeast Asia, and Latin America. Tanke Biosciences Corporation was founded in 1989 and maintains its headquarters in Guangzhou, People's Republic of China.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.10.2026 11:49

Meta is ramping up its investment in AI: increasing spending and preparing to issue a new class of shares

22.10.2026 11:15

Tesla has scaled back its capital expenditure plans for 2026. Why investors weren't pleased

22.10.2026 10:48

Top Stories This Morning: Meta Has Increased Its AI Spending; Anthropic Has Unveiled a Competitor to Muse

22.10.2026 10:33

Millions of Hacking Attempts: 5 Questions About a Critical Network Vulnerability Discovered by AI

21.10.2026 22:53

"Ambitions Greater Than Anyone Else's": JPMorgan Expects SpaceX Shares to Triple in Value

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026